1. Volpe JJ. Neurobiology of periventricular leukomalacia in the premature infant. Pediatr Res 2001;50:553–562.
2. Auten RL, Davis JM. Oxygen toxicity and reactive oxygen species: the devil is in the details. Pediatr Res 2009;66:121–127.
3. Halliwell B. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 1994;344:721–724.
4. Saugstad OD. Mechanisms of tissue injury by oxygen radicals: implications for neonatal disease. Acta Paediatr 1996;85:1–4.
5. Sarker AH, Watanabe S, Seki S, Akiyama T, Okada S. Oxygen radical-induced single-strand DNA breaks and repair of the damage in a cell-free system. Mutat Res 1995;337:85–95.
6. Perrone S, Negro S, Tataranno ML, Buonocore G. Oxidative stress and antioxidant strategies in newborns. J Matern Fetal Neonatal Med 2010;23(Suppl 3): 63–65.
7. Aspberg A, Tottmar O. Development of antioxidant enzymes in rat brain and in reaggregation culture of fetal brain cells. Brain Res Dev Brain Res 1992;66:55–58.
8. Shivakumar BR, Anandatheerthavarada HK, Ravindranath V. Free radical scavenging systems in developing rat brain. Int J Dev Neurosci 1991;9:181–185.
9. Folkerth RD, Haynes RL, Borenstein NS, Belliveau RA, Trachtenberg F, Rosenberg PA, et al. Developmental lag in superoxide dismutases relative to other antioxidant enzymes in premyelinated human telencephalic white matter. J Neuropathol Exp Neurol 2004;63:990–999.
10. Chae HZ, Chung SJ, Rhee SG. Thioredoxin-dependent peroxide reductase from yeast. J Biol Chem 1994;269:27670–27678.
11. Chae HZ, Kim HJ, Kang SW, Rhee SG. Characterization of three isoforms of mammalian peroxiredoxin that reduce peroxides in the presence of thioredoxin. Diabetes Res Clin Pract 1999;45:101–112.
13. Pak JH, Manevich Y, Kim HS, Feinstein SI, Fisher AB. An antisense oligonucleotide to 1-cys peroxiredoxin causes lipid peroxidation and apoptosis in lung epithelial cells. J Biol Chem 2002;277:49927–49934.
14. Miller SL, Wallace EM, Walker DW. Antioxidant therapies: a potential role in perinatal medicine. Neuroendocrinology 2012;96:13–23.
15. Buonocore G, Perrone S, Tataranno ML. Oxygen toxicity: chemistry and biology of reactive oxygen species. Semin Fetal Neonatal Med 2010;15:186–190.
16. Buonocore G, Perrone S, Bracci R. Free radicals and brain damage in the newborn. Biol Neonate 2001;79:180–186.
18. Finkel T. Oxygen radicals and signaling. Curr Opin Cell Biol 1998;10:248–253.
19. Rhee SG, Kang SW, Jeong W, Chang TS, Yang KS, Woo HA. Intracellular messenger function of hydrogen peroxide and its regulation by peroxiredoxins. Curr Opin Cell Biol 2005;17:183–189.
20. Burdon RH. Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic Biol Med 1995;18:775–794.
21. Rodrigo J, Fernandez AP, Serrano J, Peinado MA, Martínez A. The role of free radicals in cerebral hypoxia and ischemia. Free Radic Biol Med 2005;39:26–50.
22. Davis JM, Auten RL. Maturation of the antioxidant system and the effects on preterm birth. Semin Fetal Neonatal Med 2010;15:191–195.
23. Land SC. Oxygen-sensing pathways and the development of mammalian gas exchange. Redox Rep 2003;8:325–340.
24. Hoang VM, Foulk R, Clauser K, Burlingame A, Gibson BW, Fisher SJ. Functional proteomics: examining the effects of hypoxia on the cytotrophoblast protein repertoire. Biochemistry 2001;40:4077–4086.
25. Ozawa H, Takashima S. Immunocytochemical development of transferrin and ferritin immunoreactivity in the human pons and cerebellum. J Child Neurol 1998;13:59–63.
26. van Meer G. Transport and sorting of membrane lipids. Curr Opin Cell Biol 1993;5:661–673.
27. Adamo AM, Aloise PA, Pasquini JM. A possible relationship between concentration of microperoxisomes and myelination. Int J Dev Neurosci 1986;4:513–517.
28. Kim HS, Kang SW, Rhee SG, Clerch LB. Rat lung peroxiredoxins I and II are differentially regulated during development and by hyperoxia. Am J Physiol Lung Cell Mol Physiol 2001;280:L1212–L1217.
29. Kim HS, Pak JH, Gonzales LW, Feinstein SI, Fisher AB. Regulation of 1-cys peroxiredoxin expression in lung epithelial cells. Am J Respir Cell Mol Biol 2002;27:227–233.
30. Kim HS, Manevich Y, Feinstein SI, Pak JH, Ho YS, Fisher AB. Induction of 1-cys peroxiredoxin expression by oxidative stress in lung epithelial cells. Am J Physiol Lung Cell Mol Physiol 2003;285:L363–L369.
31. Shim SY, Kim HS, Kim EK, Choi JH. Expression of peroxiredoxin 1, 2, and 6 in the rat brain during perinatal development and in response to dexamethasone. Free Radic Res 2012;46:231–239.
32. Mizusawa H, Ishii T, Bannai S. Peroxiredoxin I (macrophage 23 kDa stress protein) is highly and widely expressed in the rat nervous system. Neurosci Lett 2000;283:57–60.
34. Savman K, Nilsson UA, Blennow M, Kjellmer I, Whitelaw A. Nonprotein-bound iron is elevated in cerebrospinal fluid from preterm infants with posthemorrhagic ventricular dilatation. Pediatr Res 2001;49:208–212.
35. Blomgren K, Hagberg H. Free radicals, mitochondria, and hypoxiaischemia in the developing brain. Free Radic Biol Med 2006;40:388–397.
36. Reiter RJ, Tan DX. Melatonin: a novel protective agent against oxidative injury of the ischemic/reperfused heart. Cardiovasc Res 2003;58:10–19.
37. Reiter RJ, Tan DX, Osuna C, Gitto E. Actions of melatonin in the reduction of oxidative stress. A review. J Biomed Sci 2000;7:444–458.
38. Palmer C, Towfighi J, Roberts RL, Heitjan DF. Allopurinol administered after inducing hypoxia-ischemia reduces brain injury in 7-day-old rats. Pediatr Res 1993;33(4 Pt 1): 405–411.
42. Nakai A, Shibazaki Y, Taniuchi Y, Oya A, Asakura H, Koshino T, et al. Vitamins ameliorate secondary mitochondrial failure in neonatal rat brain. Pediatr Neurol 2002;27:30–35.
43. Tyson JE, Wright LL, Oh W, Kennedy KA, Mele L, Ehrenkranz RA, et al. Vitamin A supplementation for extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med 1999;340:1962–1968.
44. Tin W, Wiswell TE. Drug therapies in bronchopulmonary dysplasia: debunking the myths. Semin Fetal Neonatal Med 2009;14:383–390.
45. Parad RB, Allred EN, Rosenfeld WN, Davis JM. Reduction of retinopathy of prematurity in extremely low gestational age newborns treated with recombinant human Cu/Zn superoxide dismutase. Neonatology 2012;102:139–144.